Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05358327 · ClinicalTrials.gov registry record · NA
Treatment for Lifting Upper Arm Lax Skin
A NA study, sponsored by Sofwave Medical.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT05358327: Completed NA study, sponsored by Sofwave Medical.
NCT05358327 is a NA study that has completed, run by Sofwave Medical. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05358327, a NA study, has completed, sponsored by Sofwave Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
Open-label, non-randomized, prospective, multi-center, self-controlled clinical study with masked evaluation.
Primary Outcome
following Sofwave treatment as evaluated by independent masked reviewers
Interventions
- DEVICE Sofwave
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-05-01 |
| Est. Completion | 2023-02-01 |
| Phase | NA |
What the finished NCT05358327 record still lists
NCT05358327 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Sofwave is the first listed.
NCT05358327 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05358327 about?
NCT05358327 is a clinical study titled "Treatment for Lifting Upper Arm Lax Skin". Open-label, non-randomized, prospective, multi-center, self-controlled clinical study with masked evaluation.
What is the current status of trial NCT05358327?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2022-05-01. Estimated completion is 2023-02-01.
What interventions are being tested in trial NCT05358327?
The interventions under investigation include: Sofwave (DEVICE).
Who is sponsoring clinical trial NCT05358327?
This trial is sponsored by Sofwave Medical, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05358327's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI